Novartis | 34%
Roche | 25%
Uniqure | 12%
Wave Life Science | 10%
PTC Therapeutics | 4%
Huntington’s Disease Society of America (HDSA) | 6%
European Federation of Neurological Associations (EFNA) | 3%
Associaciao Portuguese dos Doentes de Huntington | 6%